Centro Nacional de Biotecnología (CNB-CSIC)

National Biotechnology Centre (CNB-CSIC)

Information
C/ Darwin nº 3, Campus de Cantoblanco 28049 Madrid

cancer, covid-19, gene editing, rare diseases, immunology, microbiology, nanoscience, AIDS / HIV, transgenics
Contact
Susana de Lucas
Communication and scientific dissemination
divulgacion@cnb.csic.es
91 585 48 42

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Co-director of the Microbiome Analysis Laboratory and Research Professor

Co-director of the coronavirus group at the National Biotechnology Centre (CNB-CSIC)

Research professor at the National Biotechnology Centre (CNB-CSIC) and at the CIBERER-ISCIII

 

CNB-CSIC Scientific Researcher at the CiMUS of the University of Santiago de Compostela, IDIS. Laboratory of Cell Senescence, Cancer and Aging

Virologist at the National Center for Biotechnology (CNB-CSIC)

Head of the Cerebral Cortex Development research group at the National Center for Biotechnology (CNB-CSIC)

Researcher at the National Biotechnology Centre (CNB-CSIC)

Researcher specialized in ecology and evolution of antibiotic resistance.

Virologist at the National Biotechnology Centre (CNB-CSIC)

CSIC Research Professor at the National Center of Biotechnology

Contents related to this centre
covid-19

The new B.1.1.529 variant, dubbed Omicron, has spread across the globe, with new countries announcing its detection with each passing day. While questions such as whether it is more transmissible are being investigated, the biggest question surrounds its relationship with vaccines - will they cease to be effective, and will this variant escape our immune systems? Several experts answer.